For many people, this convenience factor determines product choice regardless of theoretical bioavailability differences
Prime has cultivated industry-leading insights on GLP-1 drugs, beginning with the release of its Year-1 data in July 2023, which showed 71% of individuals were no longer taking these drugs for weight loss at one year
The translational paradigm of nanobiomaterials: biological chemistry to modern applications
In a head-to-head trial published in the New England Journal of Medicine in May 2025, Mounjaro users lost 20.2 percent of body weight compared to 13.7 percent for Wegovy users
To learn how to interpret your COA, review our COA interpretation guide
They might forget main details, big ideas, or whole talks that happened not long ago